Importantly, as we have shown for the HLD-causing m6Ad-SNV in EPRS1 mRNA, pathologies induced by the newly revealed m6Ad-SNVs might be correctible by RNA-based therapeutics. The gene discussed is EPRS1; the disease is leukodystrophy.